as a reminder, in q1 2022 KM declared:
QUOTE
“US revenue enables us to ‘self-fund’ our growth strategy in Europe and internationally”.
“Our U.S. revenue is currently supporting our growth strategy”.
“We are very aware of the challenges we face with additional generic competition”.
“Our goal is to offset these challenges with a focus on operational excellence” - meaning “reducing expenses”.
“It is our objective to maintain our positive contribution margin, defined as U.S. gross profit less U.S. sales and marketing-related expenses, in the U.S.”
“We believe we are making headway in the U.S. with our go-to-market strategy, and we continue to focus on stabilizing VASCEPA revenue with this focused approach”
“Our ongoing efforts to expand provider engagements have been progressing. We are seeing the benefits of our digital omnichannel efforts”
UNQUOTE
News 
Market Data 
Discover 
AI
